Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Innocan Pharma Corp C.INNO

Alternate Symbol(s):  INNPF

Healthcare
Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the Company aims to provide a safe, non-opioid chronic pain management solutions for both animals and humans. To achieve this aim, the Company developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of... see more

Recent & Breaking News (CSE:INNO)

Innocan Pharma Announces Filing of PCT Patent Application for Vaginal Atrophy Treatment

Newsfile June 17, 2022

Innocan Reports Successful Preliminary Trial Results Regarding Epilepsy in Dogs

Newsfile June 10, 2022

Innocan Pharma Announces Q1 2022 Results with 215% Increase in Cash Balance and 200% Increase in Working Capital

Newsfile May 30, 2022

Innocan Pharma Obtains Receipt for Final Base Shelf Prospectus

Newsfile May 17, 2022

Innocan Pharma (CSE:INNO) announces patent application for its new CBD formulation

John Ballem  May 11, 2022

Innocan Pharma Announces the Successful Publication of a New Patent Application of Its New Sustained-Release (LPC) CBD Formulation

Newsfile May 11, 2022

Innocan Pharma's Compassionate Care Treatment for Dogs

Newsfile April 29, 2022

Innocan Pharma's Case Report Accepted to the 25M Readers of Frontiers Veterinary Scientific Journal

Newsfile April 11, 2022

Innocan Pharma Reports a Successful FDA-Required Characterization of Highly CBD-Loaded Liposome Platform

Newsfile March 28, 2022

Innocan Pharma Reports a Positive Result from the Use of Its CBD LPT on a Dog Suffering from Osteoarthritis

Newsfile March 8, 2022

Former Beckman Coulter Dr. Eyal Kalo to join Innocan Pharma's Expanding R&D Team

Newsfile March 4, 2022

Sony Ex-VP Dr. Kenji Kitatani to Join Innocan Pharma's Advisory Committee

Newsfile February 7, 2022

Innocan Pharma Announces Important Updates Regarding its LPT Platform Project and Commercialization Paths

Newsfile January 20, 2022

Innocan Pharma Announces the Inauguration of Its Drug Development Lab at Biohouse in the Hadassah Medical Center in Jerusalem

Newsfile January 17, 2022

InnoCan Pharma (CSE:INNO) expands CBD research into veterinary field

Trevor Abes  January 13, 2022

Innocan Pharma to Expand its LPT Platform to the Veterinary Field

Newsfile January 13, 2022

Innocan Announces the Execution of a Research & License Agreement with Ramot, the Technology Transfer Company of the Tel Aviv University for Cannabinoids Loaded Exosome Delivery Platform (CLX)

Newsfile December 9, 2021

Innocan Pharma Announces the Successful Demonstration of Prolonged Release of CDB in Dogs Using Its LPT Technology

Newsfile November 18, 2021

Innocan Pharma to Participate in the Lift & Co. Expo's Business Growth Panel on November 19th, 2021

Newsfile November 15, 2021

Innocan Pharma Reports Further Success in Profile Characterization Progress In Its micro-RNA Cannabinoids Loaded Exosome Delivery Platform (CLX) Project

Newsfile November 10, 2021